Anaprazole Sodium enteric-coated tablet

DRUG4 trials

Sponsors

Sihuan Pharmaceutical Holdings Group Ltd., Xuanzhu Biopharmaceutical Co., Ltd.

Conditions

ElderlyHELICOBACTER PYLORI INFECTIONSHealthy VolunteersHepatic InsufficiencyRenal Insufficiency

Phase 1

A Multiple Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects

CompletedNCT04466748

Sihuan Pharmaceutical Holdings Group Ltd.Healthy Volunteers

Start: 2015-09-08End: 2015-12-29Updated: 2020-07-10

A Multiple Ascending High Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects

CompletedNCT04471922

Sihuan Pharmaceutical Holdings Group Ltd.Healthy Volunteers

Start: 2019-03-21End: 2019-03-28Updated: 2020-07-15

Phase 3

The Clinical Trail to Evaluate the Efficacy and Safety of Anaprazole Sodium Enteric-coated Tablets Combined With Bismuth-containing Quadruple Therapy in Eradicating Helicobacter Pylori

Not yet recruitingNCT07606833

Xuanzhu Biopharmaceutical Co., Ltd.HELICOBACTER PYLORI INFECTIONS

Start: 2026-06-10End: 2027-03-18Target: 556Updated: 2026-05-26

Phase 4

A Study of the Pharmacokinetics and Safety of Anaprazole Sodium in Special Populations

Not yet recruitingNCT07345689

Xuanzhu Biopharmaceutical Co., Ltd.Elderly, Hepatic Insufficiency, Renal Insufficiency

Start: 2026-01-30End: 2027-06-30Target: 60Updated: 2026-01-16